首页> 外国专利> it is the first time in south diseases in diagnosis and in vivo imaging and prevention of amyloid to calm the azo compounds

it is the first time in south diseases in diagnosis and in vivo imaging and prevention of amyloid to calm the azo compounds

机译:这是南方疾病中首次诊断,体内成像和预防淀粉样蛋白以使偶氮化合物镇静的方法

摘要

according to the invention the amine g of the derivatives of the amyloid binding compounds, including medicine, science of water, and the use of the compound i is the south in the brain in vivo and to identify amyloid disease of uc6ccuc9c0 pathology symptoms is characteristic. for example, in. the diagnosis of a syndrome that is on the way. and this invention is chris amine g and the induction body contains about the assembling and the assembling use of amyloid related diseases due to increase in the cells and amyloid - induced toxicity in the prevention methods. the organization of a sword or amyloid in calm water, in order to detect color and chris amine g induction object, and use the method of the invention belong to.the black or the like, the average amount of wheat is known to be the norm for chris amine g induction object methods and the use of it.
机译:根据本发明,淀粉状蛋白结合化合物的衍生物的胺g,包括药物,水科学,以及该化合物的用途i是体内脑中的南方,并用于识别 uc6cc uc9c0病理症状的淀粉状蛋白疾病是特征。例如,在诊断即将到来的综合症。并且本发明是由预防性方法引起的,该诱导体包含由于细胞增加和淀粉样蛋白引起的毒性而引起的淀粉样蛋白相关疾病的组装和组装。剑或淀粉状蛋白在平静水中的组织,以便检测颜色和克里斯汀·克诱导物,并使用本发明的方法属于黑色或类似物,已知小麦的平均含量为标准用于克里斯·阿敏克的感应物体方法及其使用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号